Merck
MRK
$0.00 (0.00%)
1D
1W
3M
1Y
5Y
ALL
Merck & Co., Inc. is a global health care company. The Company offers health solutions through its prescription medicines, vaccines, biologic therapies and animal health Read More...Read Less
Open
Prior close
Today's high
Today's low
52 Week high
52 Week low
Business Wire • 5 hours ago • MRK
KEYTRUDA® (pembrolizumab) as Perioperative Treatment With Standard of Care (SOC) Adjuvant Therapy Significantly Improved Event-Free Survival Compared to SOC Alone in Patients With Resectable Locally Advanced Head and Neck Squamous Cell CarcinomaThe Motley Fool • 1 day ago • MRK
2 Outstanding Dividend Stocks to Buy and Hold For 20 YearsCNBC Television • 2 days ago • MRK
We're in a pharma stock pickers market, says Kessef's Len YaffeBenzinga • 2 days ago • MRK
Merck Stays Confident On M&A Despite Market Uncertainty: AnalystZacks Investment Research • 3 days ago • MRK
Merck Q1 Earnings & Sales Beat Estimates, '25 EPS Outlook CutCharts and pricing are provided for informational purposes only. The current market data is delayed up to 15 minutes. The accuracy of any market data displayed is not guaranteed.